820 / 1835
Treatment Status
•
All patients who stopped nivolumab to receive HSCT were alive at data cut-off
Disposition, n (%)
Patients
(N = 80)
Patients treated
80 (100)
Patients still on treatment
51 (64)
Patients off treatment
29 (36)
Reason off treatment
Disease progression
Study drug toxicity
Patient proceeded to allogeneic HSCT
Other: patient request, lost to follow-up, not reported, or
investigator decision
13 (16)
4 (5)
6 (8)
6 (8)
CheckMate 205B